Multiple Sclerosis

Multiple sclerosis (MS) is a severe autoimmune disease of the central nervous system that affects the brain and spinal cord, causing problems with muscle movement, balance and vision.

Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurodegenerative disorder that damages the nerves in the brain and spinal cord, leading to problems with muscle movement, balance and vision.

Types of Multiple Sclerosis (MS)

How is RRMS Different from PPMS and SPMS?

Primary Progressive Multiple Sclerosis (PPMS)

Multiple Sclerosis Epidemiology

Secondary Progressive Multiple Sclerosis (SPMS)

Remyelination Strategies for Multiple Sclerosis

Cognitive Impairment and Multiple Sclerosis

Working Towards Earlier Diagnosis of Multiple Sclerosis

Multiple Sclerosis in Children

See more featured articles »

What Causes Multiple Sclerosis?

Epigenetics for Multiple Sclerosis

Optic Neuritis and Multiple Sclerosis

Multiple Sclerosis and Pregnancy

Early Signs of Multiple Sclerosis

Multiple sclerosis and smoking

Heat Intolerance in Multiple Sclerosis

Multiple Sclerosis and Women’s Health

At-Home Physiotherapy Exercises for Multiple Sclerosis

Benign Multiple Sclerosis (MS)

Relapsing-Remitting Multiple Sclerosis (RRMS)

Multiple sclerosis and beta interferon

Anti-Myelin Antibodies in Multiple Sclerosis

Latest Multiple Sclerosis News and Research

Veterans with post-traumatic brain injury epilepsy more likely to have higher mortality rates

Military veterans who develop epilepsy after a traumatic brain injury may have a higher mortality rate in the following years than veterans who develop epilepsy with no previous traumatic brain injury, according to a study published on October 29, 2025, in Neurology®, the medical journal of the American Academy of Neurology.

30 Oct 2025

New study sheds light on vision loss in idiopathic intracranial hypertension

If untreated, a disorder of high brain pressure called idiopathic intracranial hypertension can lead to vision loss. But this disorder can develop without noticeable symptoms, making it hard to catch.

30 Oct 2025

Exploring the gut-brain-immune axis in neurodegeneration

Neurodegenerative diseases (NDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), represent a growing global health burden, particularly in aging populations.

28 Oct 2025

First multiple sclerosis patient in the UK receives CAR T cell therapy in groundbreaking trial

A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalized treatment can slow or even halt the progression of the disease.

24 Oct 2025

People with both cavities and gum disease may face higher ischemic stroke risk

People with both cavities and gum disease may face a higher risk of ischemic stroke, according to a study published on October 22, 2025, in Neurology Open Access, an official journal of the American Academy of Neurology.

23 Oct 2025

Study shows link between gum disease and white matter hyperintensities

Adults with gum disease may be more likely to have signs of damage to the brain's white matter, called white matter hyperintensities, than people without gum disease, according to a new study published on October 22, 2025, in Neurology Open Access, an official journal of the American Academy of Neurology.

23 Oct 2025

People with multiple sclerosis found to have dysbiotic oral microbiome

With ads everywhere for pro- or pre-biotic foods and supplements, most people are familiar with the gut microbiome-the trillions of bacteria, fungi, and viruses that colonize our digestive tract-and the idea that keeping our gut microbiome healthy improves our overall health.

22 Oct 2025

Blood proteins reveal MS immune system attack starts years before symptoms

By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for years. But until recently, scientists didn't understand which brain cells were being targeted or when the injury began.

21 Oct 2025

New European trial tests subcutaneous EEG technology for people with epilepsy

A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is investigating how advanced brain monitoring could improve the diagnosis and management of epilepsy.

16 Oct 2025

Caraway seeds inspire new seizure-fighting medicines

A UNLV-led team of researchers has co-opted a common kitchen spice to create a new class of cannabidiol (CBD)-like medicines that show powerful seizure-reducing effects - offering a safer, more affordable, and more effective treatment for childhood seizure disorders than existing frontline therapies.

15 Oct 2025

Discovery explains why women face higher risk of Alzheimer’s and multiple sclerosis

New research by UCLA Health has identified a sex-chromosome linked gene that drives inflammation in the female brain, offering insight into why women are disproportionately affected by conditions such as Alzheimer's disease and multiple sclerosis as well as offering a potential target for intervention.

15 Oct 2025

ALS and MS share striking geographic patterns, research shows

A new study published in Nature's Scientific Reports indicates that amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) have an extremely high geographic association, even after controlling for race, gender, wealth, latitude, and access to neurological healthcare.

15 Oct 2025

Estradiol and estriol may protect nerve function in multiple sclerosis

About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of the disease, with symptoms that worsen continuously or after periods of remission.

14 Oct 2025

How shifting antibodies fuel aging and the new therapies aiming to slow it

This review uncovers how aging reshapes immunoglobulins, particularly IgG, IgM, and IgA, driving inflammation, cellular senescence, and tissue degeneration. By dissecting B-cell dysfunction, glycosylation changes, and Fc receptor pathways, it reveals immunoglobulins as both biomarkers and potential therapeutic targets in aging.

14 Oct 2025

Discovery of unique brain cells sheds light on progressive multiple sclerosis

Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), likely contributing to the persistent inflammation characteristic of the disease.

10 Oct 2025

Common painkiller and antidepressant combo may increase seizure risk in older adults

When older adults living in nursing homes are prescribed the pain medicine tramadol alongside certain antidepressants, their risk of seizures may go up, according to a study published October 8, 2025, in Neurology, the medical journal of the American Academy of Neurology.

8 Oct 2025

New drug candidates show promise for restoring myelin in MS

Multiple sclerosis, or MS, is a chronic autoimmune disease affecting more than 2.9 million people worldwide.

8 Oct 2025

Athletes may gain health and performance advantages from time-restricted eating

According to a study by researchers at the Universitat Oberta de Catalunya (UOC), time-restricted feeding can have a positive impact on athletes in terms of both their health and performance.

8 Oct 2025

Brain stimulation may help people with multiple sclerosis cut back on excessive cannabis use

A noninvasive device that delivers weak electrical currents to the brain may help those with multiple sclerosis cut back on excessive cannabis use, a new NYU Langone Health study of women with the condition shows.

7 Oct 2025

Thermo Fisher Scientific expands neurodegeneration research capabilities with launch of Olink® Target 48 Neurodegeneration panel

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink® Target 48 Neurodegeneration panel, a high-performance, targeted proteomics immunoassay panel developed to accelerate discoveries in neurodegenerative disease research.

From Olink®- Part of Thermo Fisher Scientific 3 Oct 2025